Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1935 1
1937 1
1947 1
1948 1
1951 1
1958 1
1970 2
1971 2
1975 1
1976 2
1977 4
1980 3
1982 2
1983 2
1984 3
1986 4
1987 1
1988 1
1989 6
1990 1
1991 2
1992 2
1993 7
1994 7
1995 3
1996 4
1997 3
1998 3
1999 10
2000 5
2001 8
2002 13
2003 14
2004 14
2005 17
2006 22
2007 15
2008 17
2009 14
2010 25
2011 25
2012 22
2013 42
2014 37
2015 36
2016 29
2017 36
2018 39
2019 40
2020 48
2021 50
2022 47
2023 54
2024 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

719 results

Results by year

Filters applied: . Clear all
Page 1
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: gunther a. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension.
Veith C, Vartürk-Özcan I, Wujak M, Hadzic S, Wu CY, Knoepp F, Kraut S, Petrovic A, Gredic M, Pak O, Brosien M, Heimbrodt M, Wilhelm J, Weisel FC, Malkmus K, Schäfer K, Gall H, Tello K, Kosanovic D, Sydykov A, Sarybaev A, Günther A, Brandes RP, Seeger W, Grimminger F, Ghofrani HA, Schermuly RT, Kwapiszewska G, Sommer N, Weissmann N. Veith C, et al. Among authors: gunther a. Circulation. 2022 Mar 22;145(12):916-933. doi: 10.1161/CIRCULATIONAHA.121.057001. Epub 2022 Feb 17. Circulation. 2022. PMID: 35175782
Fatigue in Adults: Evaluation and Management.
Latimer KM, Gunther A, Kopec M. Latimer KM, et al. Among authors: gunther a. Am Fam Physician. 2023 Jul;108(1):58-69. Am Fam Physician. 2023. PMID: 37440739
Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial.
Diab M, Lehmann T, Bothe W, Akhyari P, Platzer S, Wendt D, Deppe AC, Strauch J, Hagel S, Günther A, Faerber G, Sponholz C, Franz M, Scherag A, Velichkov I, Silaschi M, Fassl J, Hofmann B, Lehmann S, Schramm R, Fritz G, Szabo G, Wahlers T, Matschke K, Lichtenberg A, Pletz MW, Gummert JF, Beyersdorf F, Hagl C, Borger MA, Bauer M, Brunkhorst FM, Doenst T; REMOVE Trial Investigators*. Diab M, et al. Among authors: gunther a. Circulation. 2022 Mar 29;145(13):959-968. doi: 10.1161/CIRCULATIONAHA.121.056940. Epub 2022 Feb 25. Circulation. 2022. PMID: 35213213 Clinical Trial.
Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis.
Kheirollahi V, Wasnick RM, Biasin V, Vazquez-Armendariz AI, Chu X, Moiseenko A, Weiss A, Wilhelm J, Zhang JS, Kwapiszewska G, Herold S, Schermuly RT, Mari B, Li X, Seeger W, Günther A, Bellusci S, El Agha E. Kheirollahi V, et al. Among authors: gunther a. Nat Commun. 2019 Jul 5;10(1):2987. doi: 10.1038/s41467-019-10839-0. Nat Commun. 2019. PMID: 31278260 Free PMC article.
Befugt oder nicht? Sauerstoffmessung im Heim.
Hasseler M, Janda C, Günther A, Czaputa E, Weidlich-Wichmann U, Lietz AL, Hartleb B. Hasseler M, et al. Among authors: gunther a. Pflege Z. 2022;75(5):16-19. doi: 10.1007/s41906-022-1246-4. Epub 2022 Apr 15. Pflege Z. 2022. PMID: 35440856 Free PMC article. Review. German.
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.
El Agha E, Moiseenko A, Kheirollahi V, De Langhe S, Crnkovic S, Kwapiszewska G, Szibor M, Kosanovic D, Schwind F, Schermuly RT, Henneke I, MacKenzie B, Quantius J, Herold S, Ntokou A, Ahlbrecht K, Braun T, Morty RE, Günther A, Seeger W, Bellusci S. El Agha E, et al. Among authors: gunther a. Cell Stem Cell. 2017 Feb 2;20(2):261-273.e3. doi: 10.1016/j.stem.2016.10.004. Epub 2016 Nov 17. Cell Stem Cell. 2017. PMID: 27867035 Free PMC article.
Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.
Hauser SL, Bar-Or A, Weber MS, Kletzl H, Günther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L. Hauser SL, et al. Among authors: gunther a. Neurol Neuroimmunol Neuroinflamm. 2023 Feb 15;10(2):e200094. doi: 10.1212/NXI.0000000000200094. Print 2023 Mar. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 36792367 Free PMC article. Clinical Trial.
CEACAM6 as a Novel Therapeutic Target to Boost HO-1-mediated Antioxidant Defense in COPD.
Wu CY, Cilic A, Pak O, Dartsch RC, Wilhelm J, Wujak M, Lo K, Brosien M, Zhang R, Alkoudmani I, Witte B, Pedersen F, Watz H, Voswinckel R, Günther A, Ghofrani HA, Brandes RP, Schermuly RT, Grimminger F, Seeger W, Sommer N, Weissmann N, Hadzic S. Wu CY, et al. Among authors: gunther a. Am J Respir Crit Care Med. 2023 Jun 15;207(12):1576-1590. doi: 10.1164/rccm.202208-1603OC. Am J Respir Crit Care Med. 2023. PMID: 37219322
719 results